SHENZHEN

ENDURING 

Current location:​
Dr. Shumin Liu (CEO)

Dr. Shumin Liu (CEO)

Sam Liu (Ph.D), CEO and co-founder.

Dr. Liu has over 20 years’ experience in biological drug development. Before he co-founded Shenzhen Enduring, he worked for Bristol-Myers Squibb to lead Clinical Manufacturing Activities, responsible for the GMP production and IND application of phase I-II clinical monoclonal antibodies. Before that, he worked for Belrose Pharma and Enzon Pharmaceuticals, INC. as a senior scientist. He is an expert in developing biological drugs, especially in developing PEGylated biological drugs. Under his leadership, two PEGylated protein drugs were approved by FDA during his 13-year tenure in Enzon pharmaceuticals, INC. Dr. Liu received his Ph.D from Penn State University in US.


0.00
0.00
  

Sam Liu (Ph.D), CEO and co-founder.

Dr. Liu has over 20 years’ experience in biological drug development. Before he co-founded Shenzhen Enduring, he worked for Bristol-Myers Squibb to lead Clinical Manufacturing Activities, responsible for the GMP production and IND application of phase I-II clinical monoclonal antibodies. Before that, he worked for Belrose Pharma and Enzon Pharmaceuticals, INC. as a senior scientist. He is an expert in developing biological drugs, especially in developing PEGylated biological drugs. Under his leadership, two PEGylated protein drugs were approved by FDA during his 13-year tenure in Enzon pharmaceuticals, INC. Dr. Liu received his Ph.D from Penn State University in US.


​ ​ Learn more
  • Dr. Shumin Liu (CEO)

    Dr. Shumin Liu (CEO)

    TEAM

    0.00

    0.00

  • David Wu (COO)

    David Wu (COO)

    TEAM

    0.00

    0.00

  • Dr. Yvonne Wen (CSO)

    Dr. Yvonne Wen (CSO)

    TEAM

    0.00

    0.00